Physician profile
Sander M Cohen
NPI 1649277351
$1,415.19
in general payments reported to CMS, 2019-2025
17 companies · $190 in 2025
The $190 reported for 2025 was less than what a typical Ophthalmology provider received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $214 · 2020: $127 · 2021: $204 · 2022: $198 · 2023: $164 · 2024: $319 · 2025: $190.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $673.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $672.69 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Johnson & Johnson Surgical Vision, INC. | $432.97 | 2019-2025 | Tecnis Iol, Veritas Vision System, Tecnis Simplicity |
| Alcon Vision LLC | $384.15 | 2020-2023 | Clareon, Hydrus Microstent |
| Abbvie INC. | $165.33 | 2022-2025 | |
| Sun Pharmaceutical Industries INC. | $110.85 | 2019-2023 | Cequa |
| Kala Pharmaceuticals, INC. | $49.38 | 2020-2021 | |
| Aerie Pharmaceuticals, INC. | $41.40 | 2021 | |
| Rxsight INC | $39.82 | 2024 | Rxsight Light Delivery Device (Ldd), Rxsight Injector Handpiece, Rxsight Contact Lens |
| New World Medical,INC. | $37.97 | 2023 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $26.46 | 2019-2021 | |
| Allergan, INC. | $23.52 | 2019 | |
| Apellis Pharmaceuticals, INC. | $20.72 | 2023 | Syfovre |
| Regeneron Healthcare Solutions, INC. | $16.48 | 2024 | Eylea |
| Bausch & Lomb Americas INC. | $15.22 | 2025 | Envista Envy Iol |
| Novartis Pharmaceuticals Corporation | $14.51 | 2019 | |
| Sight Sciences, INC. | $12.95 | 2022 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Shire North American Group INC | $12.18 | 2019 | |
| Ocular Therapeutix, INC. | $11.28 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sander Cohen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.